WallStreetZenWallStreetZen

NASDAQ: XENE
Xenon Pharmaceuticals Inc Stock Ownership - Who owns Xenon Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xenon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ian MortimerPRESIDENT CEO2025-01-271,149$17.76
$20.41kBuy
Ian MortimerPRESIDENT CEO2025-01-271,149$41.07
$47.19kSell
Ian MortimerPRESIDENT CEO2025-01-2715,166$17.76
$269.35kBuy
Ian MortimerPRESIDENT CEO2025-01-2715,166$40.46
$613.62kSell
Ian MortimerPRESIDENT CEO2025-01-2422,468$17.76
$399.03kBuy
Ian MortimerPRESIDENT CEO2025-01-2422,468$40.20
$903.21kSell
Ian MortimerPRESIDENT CEO2025-01-2316,217$17.76
$288.01kBuy
Ian MortimerPRESIDENT CEO2025-01-2316,217$40.08
$649.98kSell
Sherry AulinChief Financial Officer2024-12-189,334$9.44
$88.11kBuy
Sherry AulinChief Financial Officer2024-12-182,135$41.28
$88.13kSell

1 of 2

XENE insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XENE insiders and whales buy or sell their stock.

XENE Shareholders

What type of owners hold Xenon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC9.83%7,525,290$262.63MInstitution
Avoro Capital Advisors LLC7.40%5,666,666$197.77MInstitution
Driehaus Capital Management LLC5.91%4,520,595$157.77MInstitution
Wellington Management Group LLP4.94%3,777,611$131.84MInstitution
Braidwell LP3.81%2,913,964$101.70MInstitution
Janus Henderson Group PLC3.75%2,866,755$100.05MInstitution
Commodore Capital LP3.58%2,740,000$95.63MInstitution
Polar Capital Holdings PLC3.52%2,697,657$94.15MInstitution
Capital International Investors3.33%2,547,210$88.90MInstitution
Capital World Investors3.00%2,294,537$80.08MInstitution

1 of 3

XENE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XENE96.85%3.15%Net BuyingNet Buying
FOLD65.48%34.52%Net SellingNet Selling
ACAD71.62%28.38%Net SellingNet Selling
RXRX75.80%17.40%Net SellingNet Selling
NAMS70.99%29.01%Net SellingNet Selling
View Top Biotech Stocks

Xenon Pharmaceuticals Stock Ownership FAQ

Who owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals (NASDAQ: XENE) is owned by 99.67% institutional shareholders, 3.25% Xenon Pharmaceuticals insiders, and 0.00% retail investors. Evan A. Stein is the largest individual Xenon Pharmaceuticals shareholder, owning 1.04M shares representing 1.36% of the company. Evan A. Stein's Xenon Pharmaceuticals shares are currently valued at $36.31M.

If you're new to stock investing, here's how to buy Xenon Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.